Perspectives

As has been true for many years, cancer remains the second leading cause of death in developed countries, and oncology remains the largest therapeutic area for biopharma R&D and sales. Accordingly, Lumanity has cultivated dedicated expertise in oncology across our businesses, including strategy consulting, medical affairs, medical communications, market insight, market access, and others. Lumanity has further established an Oncology Center of Excellence where our internal oncology experts across the company coordinate, collaborate, and share insights. As 2024 wrapped up, we reflected on some noteworthy trends and events and how they may continue to unfold and impact the field in 2025. We are pleased to share with you a collection of these perspectives.

Lumanity Strategy Consulting recently participated in the 2nd Annual Cell Therapy for Autoimmune Disease Summit in early December 2024.

In collaboration with University of Sheffield's Centre for Health & Related Research, we share insights on the strengths, challenges, and projections for role of real world evidence in health technology assessment.

Discover the secrets to building a high-performing Medical Science Liaison team and advancing your career in medical affairs as Peg Crowley-Nowick, PhD, MBA, engages in a compelling discussion with Cathy Andorfer, PhD, National Director of Field Medical at Tourmaline Bio. Gain practical insights on leadership, strategic vision, and empowering your team to drive better outcomes in the latest episode of Medical Affairs Unscripted.